Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Fortschr Neurol Psychiatr ; 85(8): 474-478, 2017 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-28841746

RESUMO

Introduction Mitochondriopathies are pathologies of cell organelles, which are essential for the formation of adenosine triphosphate (ATP), which is responsible for cellular energy stock. When mitochondrial mutations occur, symptoms arise frequently in those organs that rely on a continuous energy supply, such as the nervous system. Although psychiatric illness is increasingly prevalent in patients with mitochondrial disease, less attention has been paid to its psychiatric presentations. Case Report We describe a case of a 21-year-old woman who presented in our outpatient department with panic attacks and depression. The patient experienced major side effects after low-dose sertraline therapy. Conclusion Mitochondriopathies belong to the class of rare illnesses in psychiatry; nevertheless, they require adaptations of psychopharmacological therapy. Psychotropic drugs are potential respiratory chain inhibitors and could lead to distinct side effects.


Assuntos
Doenças Mitocondriais/tratamento farmacológico , Doenças Mitocondriais/psicologia , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/etiologia , Feminino , Humanos , Doenças Mitocondriais/complicações , Testes Neuropsicológicos , Transtorno de Pânico/tratamento farmacológico , Transtorno de Pânico/etiologia , Personalidade , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Sertralina/efeitos adversos , Sertralina/uso terapêutico , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA